(Q39711573)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

14 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Bleomycin/interleukin-12 electrochemogenetherapy for treating naturally occurring spontaneous neoplasms in dogs (English)

1 reference

14 September 2017

S D Reed

1

1 reference

14 September 2017

A Fulmer

2

1 reference

14 September 2017

J Buckholz

3

1 reference

14 September 2017

B Zhang

4

1 reference

14 September 2017

J Cutrera

5

1 reference

14 September 2017

K Shiomitsu

6

1 reference

14 September 2017

S Li

7

1 reference

14 September 2017

publication date

23 April 2010

1 reference

14 September 2017

1 reference

14 September 2017

volume

17

1 reference

14 September 2017

issue

8

1 reference

14 September 2017

page(s)

571-578

1 reference

Mechanisms of cell membrane electropermeabilization: a minireview of our present (lack of ?) knowledge.

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

Electroporation advances in large animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

Transdermal drug delivery enhanced by low voltage electropulsation (LVE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

Electrochemotherapy in veterinary oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

Therapy of cancer by cytokines mediated by gene therapy approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

21 January 2018

Cancer immunoprevention

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

Experimental therapeutic approaches to adenocarcinoma: the potential of tumor cells engineered to express MHC class II molecules combined with naked DNA interleukin-12 gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

Immunotherapy of cancer by IL-12-based cytokine combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

Gene therapy of cancer with interleukin-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

Anti-angiogenic gene therapy of cancer: current status and future prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

Detection, cDNA cloning and sequencing of canine interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

Soft-tissue sarcomas in dogs: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

Application of electroporation gene therapy: past, current, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

7 January 2021

Enhanced delivery of macromolecules into cells by electroendocytosis

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

7 January 2021

Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

7 January 2021

Regression of high-grade malignancy in mice by bleomycin and interleukin-12 electrochemogenetherapy.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

7 January 2021

Electrochemotherapy for the treatment of squamous cell carcinoma in cats: A preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

7 January 2021

The dog as a cancer model

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

7 January 2021

Intratumoral bleomycin and IL-12 electrochemogenetherapy for treating head and neck tumors in dogs.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.13

7 January 2021

How to stay out of a BIND

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CGT.2010.13

Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CGT.2010.13

Identifiers

DOI

10.1038/CGT.2010.13

1 reference

14 September 2017

1 reference